default author photo

Eva Gonzàlez-Barca

Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology

SCHOLARLY PAPERS

2

DOWNLOADS

198

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial

Number of pages: 29 Posted: 12 Jun 2024
Johannes Gutenberg University Mainz - University Medical Center, University of Turin, KU Leuven - University Hospitals Leuven, University Hospital Zurich - Department of Dermatology, University of Göttingen, University of Göttingen, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Centre Hospitalier Universitaire Vaudois (CHUV), Niigata University - Division of Dermatology, The Christie NHS Foundation Trust, San Gallicano Dermatological Institute IRCCS, Université Paris Cité, Centre Hospitalier Lyon-Sud - Hospices Civils de Lyon, Tohoku University, St John's Institute of Dermatology, Ruhr University of Bochum, Schleswig-Holstein University, University of Lubeck, Kantonsspital St Gallen, Ludwigshafen Medical Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Maria Curie-Sklodowska University, University of Lodz, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Consorcio Mar Parque de Salud de Barcelona, University Hospital Zurich - Department of Dermatology, UZ Leuven Hospitals - epartment of General Medical Oncolog, Yakut Hinsah Co. Ltd, Medical University of Vienna, Johannes Gutenberg University Mainz - University Medical Center, University Hospitals Birmingham NHS Foundation Trust and Independent
Downloads 116 (613,149)
Citation 1

Abstract:

Loading...

cutaneous t cell lymphoma, maintenance treatment, resminostat, HDAC inhibitor

2.

Triplet Combination of Polatuzumab Vedotin with Rituximab and Lenalidomide in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Number of pages: 28 Posted: 28 Aug 2023
Hospital Vall D’Hebron, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Universitario Donostia, Complejo Hospitalario de Navarra, University Hospitals of Leicester NHS Trust - Department of Haematology, Hospital General Universitario Gregorio Marañon, Hospital Clínic de Barcelona - Department of Haematology, Maidstone and Tunbridge Wells NHS Trust - Oncology Centre, Nottingham University Hospitals NHS Trust - Centre for Clinical Haematology, Wayne State University - Karmanos Cancer Institute, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Syneos Health, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and New York University (NYU) - Laura and Isaac Perlmutter Cancer Center
Downloads 82 (796,622)

Abstract:

Loading...

Relapsed/Refractory DLBCL, Non-Hodgkin Lymphoma, Polatuzumab Vedotin, Lenalidomide, Circulating Tumour DNA